R&D Paving the road to functionally active antibody drugs Antibody drugs have reshaped how we treat diseases.
Oncology Understanding the tumour micro-environment – the pharmaphoru... As our understanding of oncology has increased, it’s become clear that each cancer consists of much more than just the tumour cell – a whole ecosystem of vessels, immune cells, and connective tissu
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
